ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 737건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 681 | Completed | A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients | COVID-19 | Drug: Ciclesonide Drug: Placebo |
Phase 3 | Covis Pharma S.a.r.l. | INDUSTRY | 400 | All | 12 Years ~ 100 Years | University of Buffalo, Buffalo, New York, United States |
| 680 | Completed | A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 | COVID-19 | Drug: RESP301, a Nitric Oxide generating solution Other: Standard of Care |
Phase 3 | Thirty Respiratory Limited | INDUSTRY | 19 | All | 18 Years | Imperial College Healthcare NHS Trust, St. Mary's Hospital, London, United Kingdom Royal Preston Hospital, Preston, United Kingdom |
| 679 | Completed | A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19 | Sars-CoV-2 Infection | Drug: XC221 Drug: Placebo |
Phase 3 | RSV Therapeutics LLC | INDUSTRY | 274 | All | 18 Years ~ 75 Years | Municipal Budgetary Institution of Healthcare "Central City Hospital of Novoshakhtinsk", Novoshakhtinsk, Rostov Region, Russian Federation LLC "Family Clinic", Ekaterinburg, Russian Federation Regional Budgetary Institution of Healthcare "Ivanovskaya Clinical Hospital named after Kuvaevykh", Ivanovo, Russian Federation State Budgetary Institution of Healthcare of Moscow "City Polyclinic No. 2 of the Moscow Department of Healthcare", Moscow, Russian Federation Federal Budgetary Institution of Science "Moscow Research Institute of Epidemiology and Microbiology named after G.N. Gabrichevsky" of the Federal Service for the Oversight of Consumer Protection and Welfare, Moscow, Russian Federation Limited Liability Company "Medical Center "Capital-Policy", Saint Petersburg, Russian Federation Limited Liability Company "Research Center Eco-Safety", Saint Petersburg, Russian Federation LLC "Sphere-Med", Saint Petersburg, Russian Federation Saint Petersburg State Budgetary Institution of Healthcare "City Pokrovskaya Hospital" (4th Cardiology Department), Saint Petersburg, Russian Federation Saint Petersburg State Budgetary Institution of Healthcare "City Polyclinic No. 4", Saint Petersburg, Russian Federation Regional State Budgetary Institution of Healthcare "Medical-Sanitary Unit No. 2", Tomsk, Russian Federation |
| 678 | Unknown status | A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19 | COVID-19 | Biological: Adsorbed COVID-19 (inactivated) Vaccine | Phase 4 | D'Or Institute for Research and Education, Butantan Institute | OTHER | 1200 | All | 18 Years | Hospital Gloria D'Or - Hospitais Integrados da Gavea S/A, Rio De Janeiro, Brazil D'Or Institute for Research and Education, Rio De Janeiro, Brazil |
| 677 | Not yet recruiting | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 | COVID-19 | Drug: QLS1128 Drug: Placebo |
Phase 3 | Qilu Pharmaceutical Co., Ltd. | INDUSTRY | 1220 | All | 18 Years ~ 80 Years | Qilu Pharmaceutical Co., Ltd., Jinan, Shandong, China |
| 676 | Completed | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult | Covid19 Vaccine | Biological: MVC-COV1901(S protein with adjuvant) Biological: MVC-COV1901(Saline) |
Phase 2 | Medigen Vaccine Biologics Corp. | INDUSTRY | 3854 | All | 20 Years | Changhua Christian Hospital, Changhua, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan China Medical University Hospital, Taichung, Taiwan National Cheng Kung University Hospital, Tainan, Taiwan National Taiwan University Hospital, Taipei, Taiwan Taipei Medical University Hospital, Taipei, Taiwan Taipei Municipal Wan Fang Hospital, Taipei, Taiwan Taipei Veteran General Hospital, Taipei, Taiwan Tri-Service General Hospital, Taipei, Taiwan Chang-Guang Memorial Hospital Lin-Kou, Taoyuan, Taiwan Tao-Yuan General Hospital, Taoyuan, Taiwan National Institute of Hygiene and Epidemiology, Hanoi, Vietnam |
| 675 | Completed | A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19) | SARS-CoV-2 Infection | Biological: NVX-CoV2373 | Phase 2 | Novavax | INDUSTRY | 384 | All | 18 Years ~ 65 Years | KwaPhila Health Solutions (Enhancing Care), Westridge, Durban, South Africa Josha Research, Bloemfontein, Free State, South Africa The Aurum Institute Pretoria Clinical Research Services, Pretoria, Gauteng, South Africa Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, Diepkloof, Johannesburg, South Africa Wits RHI Shandukani Research Centre, Hillbrow, Johannesburg, South Africa MERC Research (Pty) Ltd - Middelburg, Middelburg, Mpumalanga, South Africa Madibeng Centre for Research, Brits, North-West, South Africa |
